C010: Rituxan Biosimilar Stable Cell Line (CHO)
The yield of Rituxan biosimilar from the CHO stable cell line was above 1.8 g/L in a 3 liter manufacturing.
C010P: Rituximab Biosimilar, CD20 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody rituximab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rituximab.